{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:02:53Z","timestamp":1792494173245,"version":"4.5.0"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Szeged Open Access Fund","award":["5223"],"award-info":[{"award-number":["5223"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The absorption of non-steroidal anti-inflammatory drugs (NSAIDs) through the nasal epithelium offers an innovative opportunity in the field of pain therapy. Thanks to the bonding of chitosan to the nasal mucosa and its permeability-enhancing effect, it is an excellent choice to formulate microspheres for the increase of drug bioavailability. The aim of our work includes the preparation of spray-dried cross-linked and non-cross-linked chitosan-based drug delivery systems for intranasal application, the optimization of spray-drying process parameters (inlet air temperature, pump rate), and the composition of samples. Cross-linked products were prepared by using different amounts of sodium tripolyphosphate. On top of these, the micrometric properties, the structural characteristics, the in vitro drug release, and the in vitro permeability of the products were studied. Spray-drying resulted in micronized chitosan particles (2\u20134 \u03bcm) regardless of the process parameters. The meloxicam (MEL)-containing microspheres showed nearly spherical habit, while MEL was present in a molecularly dispersed state. The highest dissolved (&gt;90%) and permeated (~45 \u00b5g\/cm2) MEL amount was detected from the non-cross-linked sample. Our results indicate that spray-dried MEL-containing chitosan microparticles may be recommended for the development of a novel drug delivery system to decrease acute pain or enhance analgesia by intranasal application.<\/jats:p>","DOI":"10.3390\/pharmaceutics13050608","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T13:59:14Z","timestamp":1619099954000},"page":"608","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Physico-Chemical and In Vitro Characterization of Chitosan-Based Microspheres Intended for Nasal Administration"],"prefix":"10.3390","volume":"13","author":[{"given":"Csilla","family":"Bartos","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6726 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Varga","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6726 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5336-6052","authenticated-orcid":false,"given":"Piroska","family":"Szab\u00f3-R\u00e9v\u00e9sz","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6726 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Ambrus","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, 6726 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in Nasal Delivery Systems for Therapeutic Drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","article-title":"Intranasal Delivery: Physicochemical and Therapeutic Aspects","volume":"337","author":"Costantino","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jps.21793","article-title":"Non-Invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of Administration","volume":"99","author":"Mathias","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.colsurfb.2016.08.011","article-title":"Fabrication of an Ionic-Sensitive in Situ Gel Loaded with Resveratrol Nanosuspensions Intended for Direct Nose-to-Brain Delivery","volume":"147","author":"Hao","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_5","unstructured":"Aulton, M.E., and Taylor, K. (2018). Aulton\u2019s Pharmaceutics: The Design and Manufacture of Medicines, Elsevier. [5th ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal Drug Delivery\u2014Possibilities, Problems and Solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal Drug Delivery: How, Why and What For?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03639040903170750","article-title":"The Application of Mucoadhesive Polymers in Nasal Drug Delivery","volume":"36","author":"Jiang","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/js960500j","article-title":"Nasal Absorption of Dihydroergotamine from Liquid and Powder Formulations in Rabbits","volume":"86","author":"Marttin","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-409X(97)00067-7","article-title":"Nasal Delivery Systems and Their Effect on Deposition and Absorption","volume":"29","author":"Kublik","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejps.2009.07.003","article-title":"Preparation of Zolmitriptan\u2013Chitosan Microparticles by Spray Drying for Nasal Delivery","volume":"38","author":"Alhalaweh","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_12","unstructured":"Billotte, A., Dunn, P., Henry, B., Marshall, P., and Woods, J. (2003). Intranasal Formulations for Treating Sexual Disorders. (Application No. 10\/389,127), U.S. Patent."},{"key":"ref_13","first-page":"1","article-title":"Study on Nasal Deposition of Micro Particles and Its Relationship to Airflow Structure","volume":"1","author":"Ahmadi","year":"2016","journal-title":"Int. J. Fluid Heat Transf."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2003.12.026","article-title":"Chitosan Microspheres as a Potential Carrier for Drugs","volume":"274","author":"Sinha","year":"2004","journal-title":"Int. J. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zhao, D., Yu, S., Sun, B., Gao, S., Guo, S., and Zhao, K. (2018). Biomedical Applications of Chitosan and Its Derivative Nanoparticles. Polymers, 10.","DOI":"10.3390\/polym10040462"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.progpolymsci.2014.02.008","article-title":"Chitin and Chitosan in Selected Biomedical Applications","volume":"39","author":"Anitha","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2012.06.029","article-title":"Double Crosslinked Interpenetrated Network in Nanoparticle Form for Drug Targeting\u2014Preparation, Characterization and Biodistribution Studies","volume":"436","author":"Holban","year":"2012","journal-title":"Int. J. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-Based Drug Delivery Systems","volume":"81","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biotechadv.2009.06.007","article-title":"Application of Chitosan Microspheres for Nasal Delivery of Vaccines","volume":"27","author":"Kang","year":"2009","journal-title":"Biotechnol. Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/02652040500100139","article-title":"Preparation of Cross-Linked Chitosan Microspheres by Spray Drying: Effect of Cross-Linking Agent on the Properties of Spray Dried Microspheres","volume":"22","author":"Desai","year":"2005","journal-title":"J. Microencapsul."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"E138","DOI":"10.1208\/pt070250","article-title":"Studies on Effect of PH on Cross-Linking of Chitosan with Sodium Tripolyphosphate: A Technical Note","volume":"7","author":"Bhumkar","year":"2006","journal-title":"AAPS Pharmscitech"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1166\/jbn.2009.1067","article-title":"Chitosan\/Sodium Tripolyphosphate Nanoparticles: Preparation, Characterization and Application as Drug Carrier","volume":"5","author":"Yang","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116349","DOI":"10.1016\/j.carbpol.2020.116349","article-title":"Study on the Relationship between Crosslinking Degree and Properties of TPP Crosslinked Chitosan Nanoparticles","volume":"241","author":"Pan","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_25","unstructured":"Kumar, N. (2007). WHO Normative Guidelines on Pain Management\u2014Report of a Delphi Study to Determine the Need for Guidelines and to Identify the Number and Topics of Guidelines That Should Be Developed by WHO, Available online: https:\/\/www.who.int\/medicines\/areas\/quality_safety\/delphi_study_pain_guidelines.pdf."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejps.2016.05.031","article-title":"Effect of Solubility Enhancement on Nasal Absorption of Meloxicam","volume":"95","author":"Ambrus","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Bartos, C., Ambrus, R., Kov\u00e1cs, A., G\u00e1sp\u00e1r, R., Sztojkov-Ivanov, A., M\u00e1rki, \u00c1., Jan\u00e1ky, T., T\u00f6m\u00f6si, F., Kecskem\u00e9ti, G., and Szab\u00f3-R\u00e9v\u00e9sz, P. (2018). Investigation of Absorption Routes of Meloxicam and Its Salt Form from Intranasal Delivery Systems. Molecules, 23.","DOI":"10.3390\/molecules23040784"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/713840406","article-title":"Improved Solubility and In Vitro Dissolution of Ibuprofen from Poloxamer Gel Using Eutectic Mixture with Menthol","volume":"10","author":"Yong","year":"2003","journal-title":"Drug Deliv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2015.06.046","article-title":"Study of Sodium Hyaluronate-Based Intranasal Formulations Containing Micro- or Nanosized Meloxicam Particles","volume":"491","author":"Bartos","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ultsonch.2011.07.002","article-title":"Formulation of Poorly Water-Soluble Gemfibrozil Applying Power Ultrasound","volume":"19","author":"Ambrus","year":"2012","journal-title":"Ultrason. Sonochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal Engineering of Active Pharmaceutical Ingredients to Improve Solubility and Dissolution Rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/jps.10352","article-title":"Droplet and Particle Size Relationship and Shell Thickness of Inhalable Lactose Particles During Spray Drying","volume":"92","author":"Elversson","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jddst.2015.12.004","article-title":"In Vitro, Ex Vivo and in Vivo Performance of Chitosan-Based Spray-Dried Nasal Mucoadhesive Microspheres of Diltiazem Hydrochloride","volume":"31","author":"Kulkarni","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_34","unstructured":"(2016). 2.9. Bulk density and tapped density of powders. European Pharmacopoea 9.0, Council of Europe."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpba.2013.10.031","article-title":"Drug Release Profiles and Microstructural Characterization of Cast and Freeze Dried Vitamin B12 Buccal Films by Positron Annihilation Lifetime Spectroscopy","volume":"89","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jpba.2017.06.072","article-title":"An Overview of In Vitro Dissolution\/Release Methods for Novel Mucosal Drug Delivery Systems","volume":"147","author":"Jug","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(97)00069-0","article-title":"Microspheres as Nasal Drug Delivery Systems","volume":"29","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1021\/bm070014y","article-title":"Interactions between Alginate and Chitosan Biopolymers Characterized Using FTIR and XPS","volume":"8","author":"Lawrie","year":"2007","journal-title":"Biomacromolecules"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.carbpol.2010.06.029","article-title":"Preparation, Characterization and Evaluation of Selenite-Loaded Chitosan\/TPP Nanoparticles with or without Zein Coating","volume":"82","author":"Luo","year":"2010","journal-title":"Carbohydr. Polym."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2005.01.042","article-title":"Chitosan Nanoparticles as a Novel Delivery System for Ammonium Glycyrrhizinate","volume":"295","author":"Wu","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.carbpol.2017.08.082","article-title":"Application, Mode of Action, and In Vivo Activity of Chitosan and Its Micro- and Nanoparticles as Antimicrobial Agents: A Review","volume":"176","author":"Ma","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"ref_42","first-page":"765","article-title":"Recent Advances of Chitosan Nanoparticles as Drug Carriers","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomed."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/5\/608\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:51:22Z","timestamp":1760161882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/5\/608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["pharmaceutics13050608"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13050608","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}